Methods for using osteocalcin
AssigneeAthersys, Inc.
InventorsGeorge Mbella Ekema, Robert W. Mays, Kurt R. Brunden
Life of this patent
Estimating the term…
Loading patent…
AssigneeAthersys, Inc.
InventorsGeorge Mbella Ekema, Robert W. Mays, Kurt R. Brunden
Estimating the term…
The present invention relates to methods for using osteocalcin. The invention also relates to methods for using polynucleotides encoding osteocalcin. The invention relates to methods using the osteocalcin polypeptides and polynucleotides as a target for diagnosis and treatment osteocalcin related conditions. The invention further relates to drug-screening methods using the osteocalcin polypeptides and polynucleotides to identify agonists and antagonists for diagnosis and treatment. The invention further encompasses agonists and antagonists based on the osteocalcin polypeptides and polynucleotides. The invention further relates to agonists and antagonists identified by drug screening methods with the osteocalcin polypeptides and polynucleotides as a target. The invention further related to methods of treating a subject suffering from an osteocalcin mediated condition.
A method for identifying an agent that modulates the level or activity of osteocalcin in a cell, wherein osteocalcin is selected from the group consisting of:
The method of claim 6, wherein activation of CaR2 is determined by an assay for CaR2 activity.
A method for identifying an agent that modulates the level or activity of a nucleic acid molecule in a cell, wherein said nucleic acid molecule has a nucleic acid sequence selected from the group consisting of:
A method of treating an individual having an osteocalcin related disorder said method comprising:
A method of treating an individual having a CaR2 associated disorder said method comprising:
A method of modulating the activity of osteocalcin comprising
Dependencies are inferred from the claim text.